Upcoming Shows & Events

A UK update of Gene Expression Profiling in Early Breast Cancer using the Prosigna® PAM50 Assay

Save the date!

SPEAKER: Multiple Speakers

Nov 07, 2019

18:00 - 21:30
LOCATION: Malmaison Birmingham
1 Wharfside St
Birmingham B1 1RD (close to New Street Rail Station)


  • Professor John Bartlett, Program Director of Diagnostic Development, Ontario Institute for Cancer Research and OPTIMA Scientific Advisor
    • Reclassification of breast cancers by leading multiparametric diagnostic assays in the TEAM trial
  • Dr. Andreas Makris, Consultant in Clinical Oncology and Co-Chief Investigator of the OPTIMA Trial
    • Prosigna Clinical Evidence , NICE Review and use in UK
  • Professor Dame Lesley Fallowfield, Professor of Psycho-Oncology, University of Sussex
    • Discussing risk and uncertainty in the context of Prosigna - Risk of Recurrence (RoR) scores


18.00 -18.20: Registration and Coffee/ Tea
18.20 – 20.20: Presentations from:
18.20 – 19.00: Presentation 1 – Professor John Bartlett
19.00 – 19.40: Presentation 2 – Dr Andreas Makris
19.40 – 20.20: Presentation 3 – Dame Lesley Fallowfield
20.20 – 20.50: Panel discussion
20.50 – 21.50: Networking and Buffet Dinner

Dinner and refreshments to be provided for guests during the event. Reasonable travel expenses will be reimbursed, further information provided on registration.


Area(s) of Interest
Check all that apply

Privacy Policy